Industry Discovery & Development Partnership Program
Breakthrough T1D’s IDDP Program funds for-profit research projects developing innovative, commercially viable therapies and solutions for type 1 diabetes, with a focus on unmet clinical needs.
Funder: Breakthrough T1D
Due Dates: Rolling (Inquiries/LOIs for IDDP)
Funding Amounts: Up to $3,000,000 total over 3 years (no indirect costs allowed for IDDP); company matching funds required.
Summary: Supports for-profit organizations conducting research with commercial potential in Breakthrough T1D’s priority areas, especially therapies for type 1 diabetes.
Key Information: Contact Breakthrough T1D before applying; LOI required; indirect costs not permitted.
Description
The Industry Discovery & Development Partnership (IDDP) Program is designed to accelerate the development and translation of new therapies and solutions for type 1 diabetes (T1D) by leveraging the capabilities of for-profit industry partners. The program focuses on research projects with strong commercial potential that closely align with Breakthrough T1D’s strategic research priorities, such as advancing therapies for cardiovascular disease in people with T1D and other unmet needs. Projects may encompass clinical trials, mechanistic studies, and innovative approaches to therapy development.
Breakthrough T1D encourages collaboration between industry and academic partners, aiming to drive impactful advancements in T1D treatment and care.
